» Articles » PMID: 32705478

Red Cell Differential Width (RDW) As a Predictor of Survival Outcomes with Palliative and Adjuvant Chemotherapy for Metastatic Penile Cancer

Overview
Publisher Springer
Specialty Nephrology
Date 2020 Jul 25
PMID 32705478
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Red cell distribution width (RDW) measures red cells' size variability. Metastatic penile cancer displays poor chemotherapy response. As no validated prognostic predictor exists, we investigated whether RDW correlates independently with survival outcomes in metastatic penile cancer treated by chemotherapy.

Methods: Electronic chemotherapy files of patients with metastatic penile cancer (M1 or N3) from a large academic supra-regional centre were retrospectively analysed between 2005 and 2018. Patients were stratified into RDW > 13.9% and < 13.9%, as per published data on RDW in renal cell carcinoma. Survival time was calculated from the date of chemotherapy initiation until the date of death.

Results: 58 patients were analysed. The RDW-high group (n = 31) had a poorer survival than the RDW-low group (n = 27). Median overall survival (mOS) in all patients was 19.0 months (95% CI 13.1-24.9). mOS for RDW-high was 15.0 months (95% CI 10.1-19.9) and 37.0 months (95% CI 32.3-43.1) for RDW-low. Kaplan-Meier curves showed a clear disparity in survival (log rank p = 0.025). Cox proportional hazard ratio for death, corrected for T-stage, grade, age and deprivation score was 0.43 (p = 0.04). Sub-analysis of the M1 patients showed mOS in RDW-high of 17 m (95% CI 11.6-22.4) vs. NR; HR for death of 0.42. N3 patients' mOS in RDW-high cohort was 30 months (95% CI 4.5-55.9) vs. 13 months (95% CI 1.8-24.2) in RDW-low; HR for death was 0.30.

Conclusion: RDW correlates independently with survival outcomes in metastatic penile cancer and may act as a potential predictor of survival outcomes for patients with metastatic penile cancer receiving chemotherapy.

Citing Articles

Exploring the Link Between Obligate Anaerobe-Related Dysbiosis and Prostate Cancer Development: A Pilot Study.

Ladoukakis E, Oliver T, Wilks M, Lane E, Chinegwundoh F, Shaw G Cancers (Basel). 2025; 17(1.

PMID: 39796699 PMC: 11720123. DOI: 10.3390/cancers17010070.


Prospective study on the association between 36 human blood cell traits and pan-cancer outcomes: a mendelian randomization analysis.

Liang J, Zhou X, Lin Y, Yin H, Liu Y, Xie Z BMC Cancer. 2024; 24(1):1442.

PMID: 39578790 PMC: 11583664. DOI: 10.1186/s12885-024-13133-5.


Synergistic effect of additional anlotinib and immunotherapy as second-line or later-line treatment in pancreatic cancer: A retrospective cohort study.

Qin B, Xiong Q, Xin L, Li K, Shi W, Song Q Cancer Innov. 2024; 3(4):e123.

PMID: 38948252 PMC: 11212301. DOI: 10.1002/cai2.123.


Is red blood cell distribution width a prognostic factor for colorectal cancer? A meta-analysis.

Wen Z, Zhou X, Xiao D Front Surg. 2022; 9:945126.

PMID: 36263092 PMC: 9574073. DOI: 10.3389/fsurg.2022.945126.


Preoperative red blood cell distribution width as an independent prognostic factor in metastatic renal cell carcinoma.

Wei Z, Zhang F, Ma X, He W, Gou X, Zhang X Transl Oncol. 2022; 23:101486.

PMID: 35839619 PMC: 9287633. DOI: 10.1016/j.tranon.2022.101486.

References
1.
Patel K, Ferrucci L, Ershler W, Longo D, Guralnik J . Red blood cell distribution width and the risk of death in middle-aged and older adults. Arch Intern Med. 2009; 169(5):515-23. PMC: 2765040. DOI: 10.1001/archinternmed.2009.11. View

2.
Zyczkowski M, Rajwa P, Gabrys E, Jakubowska K, Jantos E, Paradysz A . The Relationship Between Red Cell Distribution Width and Cancer-Specific Survival in Patients With Renal Cell Carcinoma Treated With Partial and Radical Nephrectomy. Clin Genitourin Cancer. 2018; 16(3):e677-e683. DOI: 10.1016/j.clgc.2017.12.003. View

3.
Hu L, Li M, Ding Y, Pu L, Liu J, Xie J . Prognostic value of RDW in cancers: a systematic review and meta-analysis. Oncotarget. 2016; 8(9):16027-16035. PMC: 5362543. DOI: 10.18632/oncotarget.13784. View

4.
Pond G, Milowsky M, Kolinsky M, Eigl B, Necchi A, Harshman L . Concurrent chemoradiotherapy for men with locally advanced penile squamous cell carcinoma. Clin Genitourin Cancer. 2014; 12(6):440-6. DOI: 10.1016/j.clgc.2014.03.009. View

5.
Wang F, Xu G, Zhang Y, Ma L . Red cell distribution width is associated with presence, stage, and grade in patients with renal cell carcinoma. Dis Markers. 2015; 2014:860419. PMC: 4280806. DOI: 10.1155/2014/860419. View